Delivery Order SPE2DB20D1004-SPE2DB24FE7V7
- Not listed
- This is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Bromfenac Sodium 0.09% eye drops. The contract is valued at $3,011.19 and has a firm fixed price pricing type. The ultimate completion date for this order is February 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.29, is for the delivery of Bromfenac Sodium 0.07% Eye Drops in 3 mL containers. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,627.55, is for the delivery of Bromfenac Sodium 0.09% eye drops. This is a firm fixed-price delivery order contract with a completion date of November 25, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $2,720.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bromfenac Sodium 0.09% eye drops, a prescription ophthalmic medication, with a completion date of May 17, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, a prescription medication. The contract has a ceiling value of $1,303.05 and runs through February 6, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,621.71, is for the delivery of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product used to treat eye conditions. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $4,236.38 firm fixed-price contract is for the supply of 4565951611 - Bromfenac Sodium 0.09% Eye Drops in 1.7 milliliter containers. The contract has an ultimate completion date of September 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization and holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,090.80, is for the delivery of Bromfenac Sodium 0.09% eye drops, a specialty pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price, and has an ultimate completion date of November 23, 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Bromfenac Sodium 0.09% eye drops, a pharmaceutical product used for the treatment of ocular conditions. The contract has a ceiling value of $3,432.36 and a completion date of January 13, 2025. The contract is a firm fixed-price, delivery order type with no set-aside designation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Bromfenac Sodium 0.09% eye drops, with a ceiling value of $2,063.13 and a performance period through March 2025. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FE7V7Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,388.91, is for the delivery of Bromfenac Sodium 0.09% eye drops, a medication used to treat eye inflammation. The contract is a Delivery Order, with a Firm Fixed Price pricing type and an ultimate completion date of October 26, 2023. The contract was awarded on October 25, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/25/23 |